Innate Immunotherapeutics Limited
Proposed ASX code: IIL
Proposed listing date: 23 December 2013 1:00PM EDST ##
|Company contact details||
Ph: 61 2 8003 3650
|Principal Activities||Development of a drug to treat secondary progressive multiple sclerosis|
|GICS industry group||Not yet allocated|
|Issue Price||20 cents per ordinary share|
|Capital to be Raised||$10,000,000|
|Expected offer close date||11 December 2013|
# Listings dates are proposed dates for first quotation of securities set out in the entity's prospectus or information memorandum. You may not rely on this information in any way.
## Listing dates are anticipated dates for first quotation of securities set by ASX following completion of admission procedures. However, they are subject to change without notice and you may not rely on this information in any way.